289 |
TAXUS Real-World Experience from ARRIVE Registry |
Alan C. Yeung |
May. 25. 07 |
288 |
The Problem Is Exaggerated: Data From "Real-World" Registries |
Antonio Colombo |
May. 18. 07 |
287 |
SFA Stenting and the Promise of DSA in the Peripheral Circulation |
John R. Laird |
May. 18. 07 |
286 |
Future Perspectives in Peripheral Intervention |
Michael R. Jaff |
May. 18. 07 |
285 |
A Critical Appraisal of Percutaneous Aortic Valve Therapies: Device Concepts, Clinical Outcomes, and Future Projections |
Martin Bert Leon |
May. 18. 07 |
284 |
IVUS Findings in DES Thrombosis |
Gary S. Mintz |
May. 18. 07 |
283 |
Renal Failure and Contrast Nephropathy: An Overview and Considerations in the PCI Patient |
Roxana Mehran |
May. 18. 07 |
282 |
Is There a Safety Advantage in the PC Based DES Systems? Possible Mechanisms |
Alan C. Yeung |
May. 18. 07 |
281 |
The Baseline Clinical Features and Plaque Characteristics from the PROSPECT Trial |
Gregg W. Stone |
May. 18. 07 |
280 |
Virtual Histology-Clinical Application, Insights into Future Use |
Barry D. Rutherford |
May. 18. 07 |